Shares of Seattle Genetics rose 5.62% to $185.75 at 16:54 EST on Friday, after two consecutive sessions in a row of losses. NASDAQ Composite is falling 0.87% to $12,998.50, following last session’s downward trend, This seems, at the moment, a somewhat rough trend trading session today.
Seattle Genetics’s last close was $175.86, 15.18% under its 52-week high of $213.94.
Seattle Genetics’s Sales
Seattle Genetics’s sales growth is 101.2% for the ongoing quarter and 60.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 521.4% and 72.4%, respectively.
Seattle Genetics’s Revenue
Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.
Seattle Genetics’s last day, last week, and last month’s average volatility was a negative 0.47%, a negative 0.06%, and a negative 0.46%, respectively.
Seattle Genetics’s last day, last week, and last month’s high and low average amplitude percentage was 1.86%, 2.44%, and 2.98%, respectively.
Seattle Genetics’s Stock Yearly Top and Bottom Value
Seattle Genetics’s stock is valued at $185.75 at 16:54 EST, way below its 52-week high of $213.94 and way higher than its 52-week low of $90.57.
Seattle Genetics’s Moving Average
Seattle Genetics’s worth is higher than its 50-day moving average of $183.03 and higher than its 200-day moving average of $176.63.